Graphite Bio, Inc. reported raising $151 Million in an initial SEC Form D filing, from an offering of $151 Million
Amount Raised
$151 Million
Round Type
Venture
Quick answer
LENZ Therapeutics, Inc. raised $151 Million in a funding round, dated March 19, 2021. LENZ Therapeutics, Inc. is based in San Francisco, California, United States.
- How much did LENZ Therapeutics, Inc. raise?
- LENZ Therapeutics, Inc. raised $151 Million in a funding round on March 19, 2021.
- Where is LENZ Therapeutics, Inc. based and how big is it?
- LENZ Therapeutics, Inc. is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as LENZ Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Plastomics raised $3.2M on May 3, 2021.
- AVM Biotechnology raised $4.4M (Seed) on May 3, 2021.
- SentryAg Inc. raised $1.2M (Seed) on May 3, 2021.
- Ashvattha Therapeutics, LLC raised $7.7M on May 3, 2021.
- Ecovative Design raised $61M on May 3, 2021.
- Ainos, Inc. raised $20M on May 3, 2021.
Who to call at LENZ Therapeutics, Inc., and when
A new round usually means LENZ Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LENZ Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LENZ Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LENZ Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LENZ Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LENZ Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.